Skip to main content
Erschienen in: Osteoporosis International 2/2019

19.12.2018 | ORIGINAL ARTICLE

Health-related quality of life in children with osteogenesis imperfecta: a large-sample study

verfasst von: Y. Song, D. Zhao, L. Li, F. Lv, O. Wang, Y. Jiang, W. Xia, X. Xing, M. Li

Erschienen in: Osteoporosis International | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Summary

In this large-sample study, we demonstrated that osteogenesis imperfecta (OI) significantly impaired the quality of life (QoL) in children. Moderate/severe OI patients had worse QoL scores than patients with mild OI. Furthermore, the QoL for OI patients was correlated with the presence of pathogenic gene mutations.

Introduction

Osteogenesis imperfecta (OI) is a hereditary disease characterized by multiple fragility fractures and progressive skeletal deformities. No detailed investigations about the quality of life (QoL) have been carried out in a large sample of patients with OI. We evaluated the QoL and its influencing factors in a large and well-characterized OI cohort.

Methods

We used a validated questionnaire of PedsQL 4.0 to evaluate the health-related quality of life (HRQoL) of children and adolescents with OI. We compared HRQoL among patients with OI types I, III, and IV. The relationship between HRQoL and pathogenic mutations in candidate OI genes was investigated. We also evaluated the influencing factors of HRQoL in OI patients.

Results

A total of 138 children with OI and 138 healthy controls were enrolled in this study. The HRQoL scores of OI patients were 64.4 ± 30.0, 71.9 ± 22.2, 75.7 ± 24.8, 63.7 ± 24.5, and 68.9 ± 22.0 in physical, emotional, social, school functioning, and total score, respectively, which were significantly lower than those of healthy children (86.5 ± 12.7, 83.3 ± 16.0, 92.1 ± 11.8, 87.5 ± 11.8, and 87.3 ± 10.7, all p < 0.01). Moderate and severe OI (type III/IV) patients had poorer HRQoL scores than patients with mild OI (type I). Gene mutations inducing qualitative defects in type I collagen led to worse HRQoL scores than those with quantitative defects in type I collagen, except in emotional functioning. The total HRQoL score was positively correlated with family income, lumbar, and femoral bone mineral density (BMD) Z-scores and negatively correlated with disease severity and fracture frequency.

Conclusion

HRQoL was significantly impaired in OI patients, and patients with more severe OI had poorer HRQoL scores. For the first time, we found that children with qualitative defects in type I collagen had poorer HRQoL scores than those with quantitative defects in type I collagen.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Marini JC, Forlino A, Bächinger HP, Bishop NJ, Byers PH, Paepe A, Fassier F, Fratzl-Zelman N, Kozloff KM, Krakow D, Montpetit K, Semler O (2017) Osteogenesis imperfecta. Nat Rev Dis Primers 3:17052CrossRefPubMed Marini JC, Forlino A, Bächinger HP, Bishop NJ, Byers PH, Paepe A, Fassier F, Fratzl-Zelman N, Kozloff KM, Krakow D, Montpetit K, Semler O (2017) Osteogenesis imperfecta. Nat Rev Dis Primers 3:17052CrossRefPubMed
3.
4.
Zurück zum Zitat Song Y, Zhao D, Xu X, Lv F, Li L, Jiang Y, Wang O, Xia W, Xing X, Li M (2018) Novel compound heterozygous mutations in SERPINH1 cause rare autosomal recessive osteogenesis imperfecta type X. Osteoporos Int 29(6):1389–1396CrossRefPubMed Song Y, Zhao D, Xu X, Lv F, Li L, Jiang Y, Wang O, Xia W, Xing X, Li M (2018) Novel compound heterozygous mutations in SERPINH1 cause rare autosomal recessive osteogenesis imperfecta type X. Osteoporos Int 29(6):1389–1396CrossRefPubMed
5.
Zurück zum Zitat Xu XJ, Lv F, Liu Y, Wang JY, Ma DD, Asan WJW, Song LJ, Jiang Y, Wang O, Xia WB, Xing XP, Li M (2017) Novel mutations in FKBP10 in Chinese patients with osteogenesis imperfecta and their treatment with zoledronic acid. J Hum Genet 62(2):205–211CrossRefPubMed Xu XJ, Lv F, Liu Y, Wang JY, Ma DD, Asan WJW, Song LJ, Jiang Y, Wang O, Xia WB, Xing XP, Li M (2017) Novel mutations in FKBP10 in Chinese patients with osteogenesis imperfecta and their treatment with zoledronic acid. J Hum Genet 62(2):205–211CrossRefPubMed
6.
Zurück zum Zitat Barbirato C, Trancozo M, Rebouças MR, Sipolatti V, Nunes VR, Paula F. (2016) Analysis of FKBP10, SERPINH1, and SERPINF1 genes in patients with osteogenesis imperfecta. Genet Mol Res 15(3): gmr.15038665 Barbirato C, Trancozo M, Rebouças MR, Sipolatti V, Nunes VR, Paula F. (2016) Analysis of FKBP10, SERPINH1, and SERPINF1 genes in patients with osteogenesis imperfecta. Genet Mol Res 15(3): gmr.15038665
7.
Zurück zum Zitat Eyre DR, Weis MA (2013) Bone collagen: new clues to its mineralization mechanism from recessive osteogenesis imperfecta. Calcif Tissue Int 93(4):338–347CrossRefPubMedPubMedCentral Eyre DR, Weis MA (2013) Bone collagen: new clues to its mineralization mechanism from recessive osteogenesis imperfecta. Calcif Tissue Int 93(4):338–347CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Bradbury LA, Barlow S, Geoghegan F, Hannon RA, Stuckey SL, Wass JA, Russell RG, Brown MA, Duncan EL (2012) Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists. Osteoporosis Int 23:285–294CrossRef Bradbury LA, Barlow S, Geoghegan F, Hannon RA, Stuckey SL, Wass JA, Russell RG, Brown MA, Duncan EL (2012) Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists. Osteoporosis Int 23:285–294CrossRef
10.
Zurück zum Zitat Khadilkar AV, Sanwalka NJ, Chiplonkar SA, Khadilkar VV, Mughal MZ (2011) Normative data and percentile curves for dual energy X-ray absorptiometry in healthy Indian girls and boys aged 5-17 years. Bone 48(4):810–819CrossRefPubMed Khadilkar AV, Sanwalka NJ, Chiplonkar SA, Khadilkar VV, Mughal MZ (2011) Normative data and percentile curves for dual energy X-ray absorptiometry in healthy Indian girls and boys aged 5-17 years. Bone 48(4):810–819CrossRefPubMed
11.
Zurück zum Zitat Liu Y, Asan MD, Lv F, Xu X, Wang J, Xia W, Jiang Y, Wang O, Xing X, Yu W, Wang J, Sun J, Song L, Zhu Y, Yang H, Wang J, Li M (2017) Gene mutation spectrum and genotype-phenotype correlation in a cohort of Chinese osteogenesis imperfecta patients revealed by targeted next generation sequencing. Osteoporos Int 28(10):2985–2995CrossRefPubMed Liu Y, Asan MD, Lv F, Xu X, Wang J, Xia W, Jiang Y, Wang O, Xing X, Yu W, Wang J, Sun J, Song L, Zhu Y, Yang H, Wang J, Li M (2017) Gene mutation spectrum and genotype-phenotype correlation in a cohort of Chinese osteogenesis imperfecta patients revealed by targeted next generation sequencing. Osteoporos Int 28(10):2985–2995CrossRefPubMed
12.
Zurück zum Zitat Lv F, Xu X, Song Y, Li L, Asan WJ, Yang H, Wang O, Jiang Y, Xia W, Xing X, Li M (2018) Novel mutations in PLOD2 cause rare Bruck syndrome. Calcif Tissue Int 102(3):296–309CrossRefPubMed Lv F, Xu X, Song Y, Li L, Asan WJ, Yang H, Wang O, Jiang Y, Xia W, Xing X, Li M (2018) Novel mutations in PLOD2 cause rare Bruck syndrome. Calcif Tissue Int 102(3):296–309CrossRefPubMed
13.
Zurück zum Zitat Wang JY, Liu Y, Song LJ, Lv F, Xu XJ, San A, Wang J, Yang HM, Yang ZY, Jiang Y, Wang O, Xia WB, Xing XP, Li M (2017) Novel mutations in SERPINF1 result in rare osteogenesis imperfecta type VI. Calcif Tissue Int 100(1):55–66CrossRefPubMed Wang JY, Liu Y, Song LJ, Lv F, Xu XJ, San A, Wang J, Yang HM, Yang ZY, Jiang Y, Wang O, Xia WB, Xing XP, Li M (2017) Novel mutations in SERPINF1 result in rare osteogenesis imperfecta type VI. Calcif Tissue Int 100(1):55–66CrossRefPubMed
14.
Zurück zum Zitat Liu Y, Wang J, Ma D, Lv F, Xu X, Xia W, Jiang Y, Wang O, Xing X, Zhou P, Wang J, Yu W, ASAN LM (2016) Osteogenesis imperfecta type V: genetic and clinical findings in eleven Chinese patients. Clin Chim Acta 462:201–209CrossRefPubMed Liu Y, Wang J, Ma D, Lv F, Xu X, Xia W, Jiang Y, Wang O, Xing X, Zhou P, Wang J, Yu W, ASAN LM (2016) Osteogenesis imperfecta type V: genetic and clinical findings in eleven Chinese patients. Clin Chim Acta 462:201–209CrossRefPubMed
15.
Zurück zum Zitat Dogba MJ, Bedos C, Durigova M, Montpetit K, Wong T, Glorieux FH, Rauch F (2013) The impact of severe osteogenesis imperfecta on the lives of young patients and their parents—a qualitative analysis. BMC Pediatr 13:153CrossRefPubMedPubMedCentral Dogba MJ, Bedos C, Durigova M, Montpetit K, Wong T, Glorieux FH, Rauch F (2013) The impact of severe osteogenesis imperfecta on the lives of young patients and their parents—a qualitative analysis. BMC Pediatr 13:153CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Edwards TC, Patrick DL, Topolski TD (2003) Quality of life of adolescents with perceived disabilities. J Pediatr Psychol 28:233–241CrossRefPubMed Edwards TC, Patrick DL, Topolski TD (2003) Quality of life of adolescents with perceived disabilities. J Pediatr Psychol 28:233–241CrossRefPubMed
17.
Zurück zum Zitat Engelbert RH, Uiterwaal CS, Gerver WJ, van der Net JJ, Pruijs HE, Helders PJ (2004) Osteogenesis imperfecta in childhood: impairment and disability. A prospective study with 4-year follow-up. Arch Phys Med Rehab 85:772–778 Engelbert RH, Uiterwaal CS, Gerver WJ, van der Net JJ, Pruijs HE, Helders PJ (2004) Osteogenesis imperfecta in childhood: impairment and disability. A prospective study with 4-year follow-up. Arch Phys Med Rehab 85:772–778
18.
Zurück zum Zitat Hill CL, Baird WO, Walters SJ (2014) Quality of life in children and adolescents with osteogenesis imperfecta: a qualitative interview based study. Health Qual Life Outcomes 2014; 12:54 Hill CL, Baird WO, Walters SJ (2014) Quality of life in children and adolescents with osteogenesis imperfecta: a qualitative interview based study. Health Qual Life Outcomes 2014; 12:54
19.
Zurück zum Zitat Fano V, del Pino M, Rodríguez Celin M, Buceta S, Obregón MG (2013) Osteogenesis imperfecta: quality of life in children. Arch Argent Pediatr 111(4):328–331CrossRefPubMed Fano V, del Pino M, Rodríguez Celin M, Buceta S, Obregón MG (2013) Osteogenesis imperfecta: quality of life in children. Arch Argent Pediatr 111(4):328–331CrossRefPubMed
20.
Zurück zum Zitat Vanz AP, van de Sande Lee J, Pinheiro B, Zambrano M, Brizola E, da Rocha NS, Schwartz IVD, de Souza Pires MM, Félix TM (2018) Health-related quality of life of children and adolescents with osteogenesis imperfecta: a cross-sectional study using PedsQL™. BMC Pediatr 18(1):95CrossRefPubMedPubMedCentral Vanz AP, van de Sande Lee J, Pinheiro B, Zambrano M, Brizola E, da Rocha NS, Schwartz IVD, de Souza Pires MM, Félix TM (2018) Health-related quality of life of children and adolescents with osteogenesis imperfecta: a cross-sectional study using PedsQL™. BMC Pediatr 18(1):95CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Dahan-Oliel N, Oliel S, Tsimicalis A (2016) Quality of life in osteogenesis imperfecta: a mixed-methods systematic review. Am J Med Genet A 170A(1):62–76CrossRefPubMed Dahan-Oliel N, Oliel S, Tsimicalis A (2016) Quality of life in osteogenesis imperfecta: a mixed-methods systematic review. Am J Med Genet A 170A(1):62–76CrossRefPubMed
22.
Zurück zum Zitat Engelbert RH, Custers JW, van der Net J (1997) Functional outcome in osteogenesis imperfecta: disability profiles using the PEDI. Pediatr Phys Ther 9(1):18–22CrossRef Engelbert RH, Custers JW, van der Net J (1997) Functional outcome in osteogenesis imperfecta: disability profiles using the PEDI. Pediatr Phys Ther 9(1):18–22CrossRef
23.
Zurück zum Zitat Engelbert RH, van der Graaf Y, van Empelen R, Beemer FA, Helders PJ (1997) Osteogenesis imperfecta in childhood: impairment and disability. Pediatrics 99(2):E3CrossRefPubMed Engelbert RH, van der Graaf Y, van Empelen R, Beemer FA, Helders PJ (1997) Osteogenesis imperfecta in childhood: impairment and disability. Pediatrics 99(2):E3CrossRefPubMed
24.
Zurück zum Zitat Montpetit K, Dahan-Oliel N, Ruck-Gibis J, Fassier F, Rauch F, Glorieux F (2011) Activities and participation in young adults with osteogenesis imperfecta [comparative study]. J Pediatr Rehabil Med 4(1):13–22PubMed Montpetit K, Dahan-Oliel N, Ruck-Gibis J, Fassier F, Rauch F, Glorieux F (2011) Activities and participation in young adults with osteogenesis imperfecta [comparative study]. J Pediatr Rehabil Med 4(1):13–22PubMed
25.
Zurück zum Zitat Sousa T, Bompadre V, White KK (2014) Musculoskeletal functional outcomes in children with osteogenesis imperfecta: associations with disease severity and pamidronate therapy. J Pediatr Orthop 34(1):118–122CrossRefPubMed Sousa T, Bompadre V, White KK (2014) Musculoskeletal functional outcomes in children with osteogenesis imperfecta: associations with disease severity and pamidronate therapy. J Pediatr Orthop 34(1):118–122CrossRefPubMed
26.
Zurück zum Zitat Tsimicalis A, Denis-Larocque G, Michalovic A, Lepage C, Williams K, Yao TR, Palomo T, Dahan-Oliel N, Le May S, Rauch F (2016) The psychosocial experience of individuals living with osteogenesis imperfecta: a mixed-methods systematic review. Qual Life Res 25:1877–1896CrossRefPubMed Tsimicalis A, Denis-Larocque G, Michalovic A, Lepage C, Williams K, Yao TR, Palomo T, Dahan-Oliel N, Le May S, Rauch F (2016) The psychosocial experience of individuals living with osteogenesis imperfecta: a mixed-methods systematic review. Qual Life Res 25:1877–1896CrossRefPubMed
27.
Zurück zum Zitat Lindahl K, Kindmark A, Rubin CJ, Malmgren B, Grigelioniene G, Söderhäll S, Ljunggren Ö, Åström E (2016) Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate. Bone 87:11–18CrossRefPubMed Lindahl K, Kindmark A, Rubin CJ, Malmgren B, Grigelioniene G, Söderhäll S, Ljunggren Ö, Åström E (2016) Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate. Bone 87:11–18CrossRefPubMed
28.
Zurück zum Zitat Dwan K, Phillipi CA, Steiner RD, Basel D (2014) Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev D5088 Dwan K, Phillipi CA, Steiner RD, Basel D (2014) Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev D5088
29.
Zurück zum Zitat Marginean O, Tamasanu RC, Mang N, Mozos I, Brad GF (2017) Therapy with pamidronate in children with osteogenesis imperfecta. Drug Des Devel Ther 11:2507–2515CrossRefPubMedPubMedCentral Marginean O, Tamasanu RC, Mang N, Mozos I, Brad GF (2017) Therapy with pamidronate in children with osteogenesis imperfecta. Drug Des Devel Ther 11:2507–2515CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Tsimicalis A, Boitor M, Ferland CE, Rauch F, Le May S, Carrier JI, Ngheim T, Bilodeau C (2018) Pain and quality of life of children and adolescents with osteogenesis imperfecta over a bisphosphonate treatment cycle. Eur J Pediatr 177(6):891–902CrossRefPubMed Tsimicalis A, Boitor M, Ferland CE, Rauch F, Le May S, Carrier JI, Ngheim T, Bilodeau C (2018) Pain and quality of life of children and adolescents with osteogenesis imperfecta over a bisphosphonate treatment cycle. Eur J Pediatr 177(6):891–902CrossRefPubMed
31.
Zurück zum Zitat Hoyer-Kuhn H, Stark C, Franklin J, Schoenau E, Semler O (2017) Correlation of bone mineral density on quality of life in patients with osteogenesis imperfecta during treatment with denosumab. Pediatr Endocrinol Rev 15(Suppl 1):123–129PubMed Hoyer-Kuhn H, Stark C, Franklin J, Schoenau E, Semler O (2017) Correlation of bone mineral density on quality of life in patients with osteogenesis imperfecta during treatment with denosumab. Pediatr Endocrinol Rev 15(Suppl 1):123–129PubMed
32.
Zurück zum Zitat Feehan AG, Zacharin MR, Lim AS, Simm PJ (2018) A comparative study of quality of life, functional and bone outcomes in osteogenesis imperfecta with bisphosphonate therapy initiated in childhood or adulthood. Bone 113:137–143CrossRefPubMed Feehan AG, Zacharin MR, Lim AS, Simm PJ (2018) A comparative study of quality of life, functional and bone outcomes in osteogenesis imperfecta with bisphosphonate therapy initiated in childhood or adulthood. Bone 113:137–143CrossRefPubMed
33.
Zurück zum Zitat Lin HY, Chuang CK, Su YN, Chen MR, Chiu HC, Niu DM, Lin SP (2015) Genotype and phenotype analysis of Taiwanese patients with osteogenesis imperfecta. Orphanet J Rare Dis 10:152CrossRefPubMedPubMedCentral Lin HY, Chuang CK, Su YN, Chen MR, Chiu HC, Niu DM, Lin SP (2015) Genotype and phenotype analysis of Taiwanese patients with osteogenesis imperfecta. Orphanet J Rare Dis 10:152CrossRefPubMedPubMedCentral
Metadaten
Titel
Health-related quality of life in children with osteogenesis imperfecta: a large-sample study
verfasst von
Y. Song
D. Zhao
L. Li
F. Lv
O. Wang
Y. Jiang
W. Xia
X. Xing
M. Li
Publikationsdatum
19.12.2018
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 2/2019
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-018-4801-5

Weitere Artikel der Ausgabe 2/2019

Osteoporosis International 2/2019 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.